Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PW Medtech Group Ltd. ( (HK:1358) ) just unveiled an update.
PW Medtech Group Limited has scheduled a board meeting for 27 March 2026 to review and approve the consolidated annual results for the year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the company’s financial performance.
The announcement also confirms the current board composition, with one executive director, two non-executive directors and three independent non-executive directors. This governance structure highlights the presence of independent oversight at the board level, which is relevant for investors assessing corporate governance and decision-making around upcoming financial disclosures and potential dividend policy.
The most recent analyst rating on (HK:1358) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on PW Medtech Group Ltd. stock, see the HK:1358 Stock Forecast page.
More about PW Medtech Group Ltd.
PW Medtech Group Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the medical technology and healthcare sector. The group focuses on medical products and services through its subsidiaries, targeting hospital and healthcare markets in China and potentially broader Asian markets.
Average Trading Volume: 705,535
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.6B
See more data about 1358 stock on TipRanks’ Stock Analysis page.